1. Background
2. Objectives
3. Methods
4. Results
4.1. Socio-Demographic Characteristics
| Socio-Demographic Variables | Values (N = 135) |
|---|---|
| Age, y | |
| < 20 | 08 (5.92) |
| 20 - 30 | 33 (24.44) |
| 30 - 4 | 46 (34.07) |
| 40 - 50 | 35 (25.92) |
| > 50 | 13 (9.62) |
| Gender | |
| Male | 105 (77.77) |
| Female | 30 (22.22) |
| Marital status | |
| Married | 92 (68.14) |
| Unmarried | 43 (31.85) |
| Family type | |
| Nuclear | 102 (75.55) |
| Joint | 33 (24.44) |
| Residence | |
| Urban | 78 (57.77) |
| Rural | 57 (42.22) |
| Religion | |
| Muslim | 130 (96.29) |
| Hindu | 05 (3.70) |
| Education level | |
| Illiterate | 09 (6.66) |
| Primary | 68 (50.37) |
| High school | 39 (28.88) |
| Graduate | 16 (11.85) |
| Postgraduate | 03 (2.22) |
| Employment | |
| Unemployed | 26 (19.25) |
| Govt. employee | 33 (24.44) |
| Farmer | 08 (5.92) |
| Labor | 09 (6.66) |
| Student | 08 (5.92) |
| Business | 20 (14.81) |
| Other | 31 (22.96) |
aValues are expressed as No. (%).
4.2. The Pattern of Substance Abuse
| Substance of Abuse | Values |
|---|---|
| Nicotine | 85 (62.96) |
| Dependence | 80 (59.26) |
| Abuse | 5 (3.7) |
| Cannabis | 15 (11.11) |
| Dependence | 13 (9.62) |
| Abuse | 2 (1.48) |
| Opioid | 15 (11.11) |
| Dependence | 14 (10.37) |
| Abuse | 1 (0.74) |
| Sedative and Hypnotic | 12 (8.88) |
| Dependence | 7 (5.19) |
| Abuse | 5 (3.7) |
| Volatile substance | 8 (5.92) |
| Dependence | 5 (3.7) |
| Abuse | 3 (2.22) |
aValues are expressed as No. (%).
4.3. Co-Morbidities Associated with Substance Use
| Co-Morbidities | Values |
|---|---|
| Psychiatric disorder | 44 (32.6) |
| Mood disorders (bipolar disorders) | 14 (10.37) |
| Major depressive disorder (MDD) | 9 (6.66) |
| Schizophrenia | 7 (5.18) |
| Anxiety | 5 (3.70) |
| Personality disorders | 5 (3.70) |
| Post-concussional syndrome | 1 (0.74) |
| Obsessive convulsive disorder | 1 (0.74) |
| Conduct disorder | 1 (0.74) |
| Hypochondriasis | 1 (0.74) |
| Neurological disorder | 32 (23.7) |
| Seizure | 24 (17.77) |
| Peripheral neuropathy | 5 (3.70) |
| EPS | 1 (0.74) |
| Head injury | 2 (1.48) |
| Infections | 10 (7.4) |
| Hepatitis | 8 (5.92) |
| Lower respiratory tract infection | 2 (1.48) |
| Gastrointestinal disorder | 9 (6.0) |
| UGI bleed | 4 (2.96) |
| Cholecystitis | 3 (2.22) |
| Pancreatitis | 1 (0.74) |
| Hepatic steatosis | 1 (0.74) |
| Cardiovascular disorder | 8 (5.9) |
| Hypertension | 6 (4.44) |
| Heart failure | 1 (0.74) |
| Infarction | 1 (0.74) |
| Endocrinology disorder | 4 (2.96) |
| Diabetes | 2 (1.48) |
| Hyperuricemia | 1 (0.74) |
| Hypothyroidism | 1 (0.74) |
| Dermatological disorder | 3 (2.0) |
| Psoriasis | 1 (0.74) |
| Skin lesions | 1 (0.74) |
| Tinea corporis | 1 (0.74) |
| Orthopedic disorder | 3 (2.0) |
| Rib fracture | 1 (0.74) |
| Volar Barbiton’s fracture | 1 (0.74) |
| limb fracture | 1 (0.74) |
| Other disorder | 9 (6.0) |
| Leg ulcer | 2 (1.48) |
| Other body injury | 3 (2.22) |
| Chronic mastoiditis | 1 (0.74) |
| Anemia | 1 (0.74) |
| Hyperbilirubinemia | 1 (0.74) |
| Hyperglycemia | 1 (0.74) |
aValues are expressed as No. (%).
4.4. Indicators of Prescribing Patterns
| Prescription Indicators | Values |
|---|---|
| Number of drugs per prescription | |
| 1 - 4 | 17 (12.59) |
| 4 - 8 | 54 (40) |
| 8 - 12 | 52 (38.51) |
| > 12 | 12 (8.88) |
| Percentage of medication | |
| Percentage number of drugs per encounter | 8.48 |
| Percentage of drugs prescribed by generic name | 21.56 |
| Percentage of encounter with an antibiotic prescribed | 35.86 |
| Percentage of encounter with an injection prescribed | 83.45 |
| Percentage of drugs prescribed from NLEM (National List of Essential Medicines) | 59.18 |
aValues are expressed as No. (%).